We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JCAP
2276
DELISTED
Jernigan Capital, Inc.
JCAP
| $625K | ﹤0.01% |
32,675
+197
| +0.6% | +$3.62K |
|
|
AXDX
2277
DELISTED
Accelerate Diagnostics
AXDX
| $624K | ﹤0.01% |
3,691
+26
| +0.7% | +$4.29K |
|
2278
Quince Therapeutics
QNCX
$28.2M
| $622K | ﹤0.01% |
+55
| New | +$332K |
|
2279
AMC Entertainment Holdings
AMC
$2.38B
| $621K | ﹤0.01% |
8,577
+47
| +0.6% | +$4.14K |
|
2280
e.l.f. Beauty
ELF
$5.09B
| $621K | ﹤0.01% |
38,517
+194
| +0.5% | +$3.23K |
|
2281
Digital Turbine
APPS
$1.59B
| $620K | ﹤0.01% |
86,934
+4,366
| +5% | +$32.5K |
|
2282
NN Inc
NNBR
$301M
| $620K | ﹤0.01% |
67,031
+535
| +0.8% | +$4.29K |
|
|
HPR
2283
DELISTED
HighPoint Resources Corporation
HPR
| $620K | ﹤0.01% |
7,333
+245
| +3% | +$15.9K |
|
|
AMNB
2284
DELISTED
American National Bankshares Inc
AMNB
| $620K | ﹤0.01% |
15,673
+109
| +0.7% | +$4.06K |
|
|
WIFI
2285
DELISTED
Boingo Wireless, Inc.
WIFI
| $616K | ﹤0.01% |
56,244
+391
| +0.7% | +$4.24K |
|
2286
Vishay Precision Group
VPG
$978M
| $612K | ﹤0.01% |
17,990
+167
| +0.9% | +$5.61K |
|
2287
Camping World
CWH
$670M
| $609K | ﹤0.01% |
41,312
-676
| -2% | -$7.65K |
|
2288
Old Second Bancorp
OSBC
$1.32B
| $609K | ﹤0.01% |
45,223
+179
| +0.4% | +$2.23K |
|
|
BDSI
2289
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $606K | ﹤0.01% |
95,923
+8,253
| +9% | +$48.5K |
|
|
STML
2290
DELISTED
Stemline Therapeutics, Inc.
STML
| $599K | ﹤0.01% |
56,322
+1,924
| +4% | +$19.1K |
|
2291
Q32 Bio
QTTB
$490M
| $596K | ﹤0.01% |
1,599
+16
| +1% | +$4.58K |
|
|
EBTC
2292
DELISTED
Enterprise Bancorp
EBTC
| $589K | ﹤0.01% |
17,399
+203
| +1% | +$6.28K |
|
2293
Bloom Energy
BE
$69B
| $587K | ﹤0.01% |
78,568
+871
| +1% | +$4.22K |
|
2294
Luxfer Holdings
LXFR
$458M
| $584K | ﹤0.01% |
31,540
+574
| +2% | +$9.88K |
|
|
LORL
2295
DELISTED
Loral Space and Communications, Inc.
LORL
| $584K | ﹤0.01% |
18,059
+155
| +0.9% | +$5.68K |
|
|
DVAX
2296
DELISTED
Dynavax Technologies
DVAX
| $582K | ﹤0.01% |
101,826
+6,104
| +6% | +$32.6K |
|
2297
Kura Oncology
KURA
$817M
| $580K | ﹤0.01% |
42,200
+1,739
| +4% | +$25.8K |
|
|
RST
2298
DELISTED
ROSETTA STONE INC
RST
| $579K | ﹤0.01% |
31,903
+431
| +1% | +$7.34K |
|
|
ACR
2299
ACRES Commercial Realty
ACR
$104M
| $576K | ﹤0.01% |
16,269
+101
| +0.6% | +$3.54K |
|
2300
Ameresco
AMRC
$1.36B
| $576K | ﹤0.01% |
32,886
+361
| +1% | +$5.68K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.